Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the third quarter of 2013.
Results for the three months ended September 30, 2013:
•Total revenue was $80.4 million, which included revenue from eBioscience of $19.9 million.
•Product revenue was $74.8 million, as compared to product revenue for the third quarter of 2012 of $72.7 million, an increase of almost 3%.
Help employers find you! Check out all the jobs and post your resume.